Week 1 Flashcards
Agonist
A drug that binds to and activates a receptor. Can be full, partial or inverse. A full agonist has high efficacy, producing a full response while occupying a relatively low proportion of receptors. A partial agonist has lower efficacy than a full agonist. It produces sub-maximal activation even when occupying the total receptor population, therefore cannot produce the maximal response, irrespective of the concentration applied. An inverse agonist produces an effect opposite to that of an agonist, yet it binds to the same receptor binding-site as an agonist.
Efficacy
Describes the way that agonists vary in the response they produce when they occupy the same number of receptors. High efficacy agonists produce their maximal response while occupying a relatively low proportion of the total receptor population. Lower efficacy agonists do not activate receptors to the same degree and may not be able to produce the maximal response.
Potency
A measure of the concentrations at which a drug is effective.
Desensitization
A reduction in response to an agonist while it is continuously present at the receptor, or progressive decrease in response upon repeated exposure to an agonist.
Duration of Action
The length of time that particular drug is effective. Duration of action is a function of several parameters including plasma half-life, the time to equilibrate between plasma and target compartments, and the off rate of the drug from its biological target.
Silent Antagonist
A drug that attenuates the effects of agonists or inverse agonists, producing a functional reduction in signal transduction. Affects only ligand-dependent receptor activation and displays no intrinsic activity itself. Also known as a neutral antagonist.
Half-life
The metabolic half-life of a drug in vivo is the time taken for its concentration in plasma to decline to half its original level. Half-life refers to the duration of action of a drug and depends upon how quickly the drug is eliminated from the plasma. The clearance and distribution of a drug from the plasma are therefore important parameters for the determination of its half-life.
Mechanism of action
Refers to the specific biochemical interaction through which a drug substance produces its pharmacological effect.
Therapeutic Window
The amount of a medication between the amount that gives an effect (effective dose) and the amount that gives more adverse effects than desired effects. For instance, medication with a small pharmaceutical window must be administered with care and control, e.g. by frequently measuring blood concentration of the drug, since it easily loses effects or gives adverse effects.
B Max
The maximum amount of drug which can bind specifically to the receptors in a membrane preparation. Can be used to measure the density of the receptor site in a particular preparation.
What schedule drugs can APRNs prescribe?
Schedule II, III, IV and V drugs.
Schedule I drugs have no medical use and high potential for abuse (heroin, ecstasy, marijuana etc)
Pharmacokinetics
The study of drug movement through the body
Pharmacodynamics
The study of the biochemical and physiological effects of drugs on the body and molecular mechanisms by which those effects are produced.
Basic processes of Pharmacokinetics
- Absorption
- Distribution
- Metabolism
- Excretion
Absorption
A drug’s movement from the site of administration into the blood
Distribution
A drug’s movement from the site of administration into the blood
Metabolism
aka - biotransformation
Enzymatically mediated alteration of drug structure
Excretion
The movement of drugs and their metabolites out of the body
CYP450
Liver enzyme that metabolizes drugs which can be inhibited or induced by drugs and when this happens drug-drug interactions occur
Who determines prescriptive authority?
Determined by state law.
Who regulates prescriptive authority?
Under the jurisdiction of a professional health board (Nursing, medicine, pharmacy)
How does limited prescriptive authority impact patients within the healthcare system?
Creates barriers to quality, affordable, accessible patient care.
May prevent outreach to areas of greatest need (NP needs MD and none in the area)
Can increase prescription wait time (cosigning)
What are the key responsibilities of prescribing?
Having a sound understanding of drugs and the condition they are used to manage
What elements should be used to make prescribing decisions?
o Cost
o Current treatment guidelines
o Availability of medication
o Interactions with other medications
o Side effects
o Allergies
o Hepatic and renal function
o Need for monitoring
o Special populations (children and the elderly)
Pharmacokinetic changes in older adults
- Decreased ability of the liver to metabolize drugs
- higher concentration of drugs in the blood
- Decreased kidney function to excrete drugs - they stay in the bloodstream longer
- Increased drug sensitivity (reduced hepatic and renal elimination)
- Potential for increased variability in drug function
- potential for more intense effects
- need to reduce dosages
Older adults - changes in drug absorption
Slower rate of absorption, delayed drug response, gastric acidity may alter absorption
* Increased gastric pH
* Decreased surface area for absorption
* Decreased GI motility
* Delayed gastric emptying
* Decreased splanchnic blood floor